Member Info for BodRuncie

@Smartinvestment, a couple of weeks ago you were speculating that a massive deal was being struck with Unilever.

What has caused you to change your mind on that?

At the 37-minute mark, Paul Hill and John Hughman discuss HVO for about 5 minutes.

Hughman owns and is very bullish. Of course he's talking his own book, but I think his comments echo a lot of investor sentiment at the moment.

https://www.youtube.com/watch?v=lDgZmvy6pdQ

Duke sold out recently with a loss.

Nick is still listed as a major shareholder, no Tr1 from him, so I presume he's still holding?

5p?

F@#k off.

It's about time. The great mgmt and value they are building have been evident for some time, now the numbers are reflecting the progress that has been made.

24th April 2023 was last year's TU.

But an RNS before then wouldn't go amiss ;)

Finseta sounds rubbish, like they deal in bitcoin and AI and will show up as advertising in my twitter feed.

Cornerstone sounds much classier.

That's alright, need liquidity to allow new buyers in.

This will help create a more stable platform for the next leg up.

5-10% isn't really a meaningful trade in the grand scheme of things. PIs have to hold longer for bigger gains, and I'm here for the foreseeable.

For a £15m mcap AIM company? Absolutely. That's how MMs make their money.

For PIs to make money, you need either to gamble on short term movements, or hold for the medium-to-long term.

Good to see everything is still progressing well.

Big German client's production has just started, and will start to show in the next set of figs.

H2 weighting is continuing, so a 50% increase over H1.

Cashburn expected to reduce to USD 1m per month in H2.

Still on track for breakeven during FY25 and company is fully funded up to then.

Fantastic results, but 2p dividend isn't 6%. More like 1.5%.

I am still erring on the side of caution.

Divis won't come anywhere near 10% yield. 1-2% is more likely. This is a progressive divi policy, it's not a divi paying stock like LGEN.

@dougerboy,

if you're interested in the fascinating properties of stereochemistry (is that an oxymoron...? No...), check out the story behind Thalidomide.

It's a 50/50 mixture (aka a racemic mixture) of two stereoisomers. One isomer has all the wonderful anti-sickness properties, but the other is the teratogenic form (the one that caused the birth-defects).

Nowadays scientists could separate the isomers and release a form that only has the good stereoisomer, however... the human body interconverts them! So our own body would produce a 50/50 mixture of the isomers regardless of which was initially given.

It's an interesting tale, and thalidomide is making a comeback, for some types of disease:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936918/

I don't wish to sound negative on the company (or get into an argument), but using the metrics the company highlighted in their broker consensus forecast RNS yesterday:

Revenue: consensus (318.4) vs actual (318.4)

EBITDA: consensus (89.2) vs actual (91.8)

NPAT (adj): consensus (35.3) vs actual (35.5)

Net debt: consensus (71.7) vs actual (69.8)

don't scream Ahead of Expectations to me.

Operating Profit is up (55.1 vs 60.3), which highlights that underneath all the complex moving parts the company is sensibly managed and is heading in the right direction.

"Ahead of expectations" might be over-egging it, it was more like an "in-line", but I am pleased with the direction of travel.

The newer aspects of the business: the investments, MSALABS, the increased US presence, are all indicators of a future 'ahead of expectations".

CAPD nicely positioning the company for the future.

Yes, it's great to feel that positive momentum again in the ITX share price.

Bizarre really, because it's now back at the last placing price, which should have been the floor. It was ridiculous that the sp ever dropped as low as it did.

But I held my shares and increased my holding by a decent amount, and ITX is now my largest holding.

These are the times when research and patience pays off for us PIs. And I would like to thank all the tireless researchers on this board who kept plugging away even as the share price plummeted. Your input has been most reassuring.

Many PIs engage with the stock market, and do research, using social media platforms like Twitter, so why not spend a little in advertising to get the message out?

Quite a canny move, imo.

It's just a shame they are putting money into the pocket of Elno :(

A £20k buy at 1309p to kick it up a notch this morning.

Someone is confident!

Odd that the share price has dropped over the past few weeks if Darren Carter bought 3% of the company on the open market...?

But the second RNS today shows Praetura Group have sold out of their 3.5% holding. Darren Carter is most likely the same Darren Carter that is a NED of Peel Hunt and Praetura Group, so it's likely that DC picked up 3% of Praetura's holding.

The other c0.5% were probably either sold to someone who doesn't have to disclose their holding of on the open market.

33p is still is a good bet for the risk-reward on offer here.

Maybe TB is very confident in the business, or wants voting bloc power (to say no more raises?), without breaching 30%.

But whatever reason, it's because he thinks there's money to be made at these levels.